Georgia Retina
Marietta, Georgia, United States
Eye care center in Marietta, Georgia
833 Campbell Hill Street Northwest #300 Ste. 300, Marietta, GA 30060
About Georgia Retina
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Georgia Retina
During the past decade, Georgia Retina conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
1998-10-01
2004-10-01
Completed
1,691
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
2001-02-01
2006-05-01
Completed
73
Combination Chemotherapy in Treating Patients With Bladder Cancer
2004-03-01
2009-04-01
Completed
42
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
2002-10-01
2008-10-01
Completed
67
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
2002-11-01
2010-01-01
Completed
71
Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
2002-07-01
Completed
449
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
2003-10-01
2012-11-01
Completed
732
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Retina"
#1 collaborator was "Stada Arzneimittel AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Georgia Retina
According to Clinical.Site data, the most researched conditions in "Georgia Retina" are
"Geographic Atrophy" (1 trials), "Macular Degeneration" (1 trials), "Neovascular Age-related Macular Degeneration" (1 trials) and "Nonproliferative Diabetic Retinopathy" (1 trials). Many other conditions were trialed in "Georgia Retina" in a lesser frequency.
Clinical Trials Intervention Types at Georgia Retina
Most popular intervention types in "Georgia Retina" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "AKB-9778" (1 trials), "APL-2" (1 trials), "Placebo" (1 trials), "Ranibizumab" (1 trials) and "Sham Procedure" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Georgia Retina
The vast majority of trials in "Georgia Retina" are
4 trials for "All" genders.
Clinical Trials Status at Georgia Retina
Currently, there are NaN active trials in "Georgia Retina".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Georgia Retina,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Georgia Retina, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".